Biocatalytic Production of Psilocybin and Derivatives in Tryptophan Synthase-Enhanced Reactions.


Psilocybin (4-phosphoryloxy-N,N-dimethyltryptamine) is the main alkaloid of the fungal genus Psilocybe, the so-called "magic mushrooms." The pharmaceutical interest in this psychotropic natural product as a future medication to treat depression and anxiety is strongly re-emerging. Here, we present an enhanced enzymatic route of psilocybin production by adding TrpB, the tryptophan synthase of the mushroom Psilocybe cubensis, to the reaction. We capitalized on its substrate flexibility and show psilocybin formation from 4-hydroxyindole and l-serine, which are less cost-intensive substrates, compared to the previous method. Furthermore, we show enzymatic production of 7-phosphoryloxytryptamine (isonorbaeocystin), a non-natural congener of the Psilocybe alkaloid norbaeocystin (4-phosphoryloxytryptamine), and of serotonin (5-hydroxytryptamine) by means of the same in vitro approach.


PubMed ID: 29750381

Projects: B05

Publication type: Journal

Journal: Chemistry

Citation: Chemistry. 2018 May 11. doi: 10.1002/chem.201801047.

Date Published: 11th May 2018

Registered Mode: by PubMed ID

Authors: F. Blei, F. Baldeweg, J. Fricke, D. Hoffmeister

help Submitter

Views: 422

Created: 10th May 2021 at 13:58

help Tags

This item has not yet been tagged.

help Attributions


Related items

Powered by
Copyright © 2008 - 2021 The University of Manchester and HITS gGmbH